My educational background is Clinical Medicine/General Surgery and I worked as a hepatobiliary surgeon in my country. I was registered as a PhD student at Professor Torkel B. Brismar Group in June 2018.
Research fields: liver function; liver growth/regeneration; gadoxetic acid enhanced MRI; radiomics & machine learning; hepatocellular carcinoma.
My PhD study is centered around how to accurately evaluate the liver function, especially the future liver remnant part, in patients with hepatocellular carcinoma before liver resection. We aim to establish non-invasive, accurate and reliable imaging biomarkers to evaluate (regional) liver function quantitatively based on preoperative gadoxetic acid enhanced MRI. With an ever-growing progress of artificial intelligence in the medical field, my current research is also making an attempt to apply machine learning approach (such as radiomics) to evaluate liver function, for instance to predict post-hepatectomy liver failure. We expect our research findings can supply a comprehensive estimation of the liver function for patients before liver resection, increase the number of patients as candidates for liver resection and assist to provide a safer and successful operation.
Multimodal perioperative assessment of liver function and volume in patients undergoing hepatectomy for colorectal liver metastasis: a comparison of the indocyanine green retention test, 99mTc mebrofenin hepatobiliary scintigraphy and gadoxetic acid enhanced MRI.
Wang Q*, Brismar TB, Gilg S, Jonas E, Nilsson H, Tzortzakakis A, Isaksson B, Axelsson R, Sparrelid E.
British Journal of Radiology. 2022 Sep 16:20220370. doi: 10.1259/bjr.20220370.
Qu C, Wang Q*, Li C, Xie Q, Cai P, Yan X, Sparrelid E, Zhang L, Ma K, Brismar TB.
Frontiers in Oncology. 2022 May 19;12:831795. doi: 10.3389/fonc.2022.831795.
Quantitative evaluation of liver function with gadoxetic acid enhanced MRI: Comparison among signal intensity-, T1-relaxometry-, and dynamic-hepatocyte-specific-contrast-enhanced MRI- derived parameters.
Wang Q, Kesen S, Liljeroth M, Nilsson H, Zhao Y, Sparrelid E, Brismar TB.
Scandinavian journal of Gastroenterology. 2022 Feb 2:1-8. doi: 10.1080/00365521.2022.2032321. Epub ahead of print.
Chen Y, Chen D, Wang Q, Xu Y, Huang X, Haglund F, Su H.
Frontiers in Immunology. 2022 Jan 17;12:719105. doi: 10.3389/fimmu.2021.719105.
Wang Q, Li C, Zhang J, Hu X, Fan Y, Ma K, Sparrelid E, Brismar TB.
Cancers (Basel). 2021 Nov 22;13(22):5864. doi: 10.3390/cancers13225864.
Sequential Portal Vein Embolization and Percutaneous Radiofrequency Ablation for Future Liver Remnant Growth: A Minimally Invasive Alternative to ALPPS Stage-1 in Treatment of Hepatocellular Carcinoma.
Wang Q, Ji Y, Brismar TB, Chen S, Li C, Jiang J, Mu W, Zhang L, Sparrelid E, Ma K.
Frontiers in Surgery. 2021 Sep 30;8:741352. doi: 10.3389/fsurg.2021.741352.
Wang Q, Wang A, Sparrelid E, Zhang J, Zhao Y, Ma K, Brismar TB.
European Radiology. 2021 Sep 25. doi: 10.1007/s00330-021-08297-8. Epub ahead of print.
Wang Q, Chen S, Yan J, Brismar T, Sparrelid E, Qu C, Ji Y, Chen S, Ma K.
BMC Surgery. 2021 May 18;21(1):246. doi: 10.1186/s12893-021-01241-z.
Academic honours, awards and prizes
Medicinsk Diagnostik Karolinska Kliniknära FoU 2022.
Member of National Clinical Research School in Chronic Inflammatory Diseases (NCRSCID) (2020-2022).